USFDA approves 1st treatment for Ebola

Context: The The Food and Drug Administration approved the first drug for the treatment of Ebola.

• It is developed by Regeneron Pharmaceuticals for treating adults and children.
• It was tested during an outbreak in Congo that killed nearly 2,300 people before it ended in June.

Inmazeb (IN’-meh-zehb)

• The drug, named Inmazeb (IN’-meh-zehb), dramatically increased survival in study participants, compared to three other treatments.
• Regeneron’s treatment is a combination of three antibodies that work by killing the virus.

Ebola virus disease

• It is a viral hemorrhagic fever of humans and other primates caused by ebolaviruses.
• It is a rare but severe, often fatal illness in humans.
• The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
• The FDA approved the first vaccine for Ebola in last December.
• An Ebola vaccine, rVSV-ZEBOV, was approved in the United States in December 2019. It appears to be fully effective ten days after being given.

https://www.thehindu.com/news/international/usfda-approves-1st-treatment-for-ebola/article32858687.ece?homepage=true